@article{38676fd3439b4da89b193b920b55ad99,
title = "Regional iron distribution and soluble ferroprotein profiles in the healthy human brain",
abstract = "Iron is essential for brain development and health where its redox properties are used for a number of neurological processes. However, iron is also a major driver of oxidative stress if not properly controlled. Brain iron distribution is highly compartmentalised and regulated by a number of proteins and small biomolecules. Here, we examine heterogeneity in regional iron levels in 10 anatomical structures from seven post-mortem human brains with no apparent neuropathology. Putamen contained the highest levels, and most case-to-case variability, of iron compared with the other regions examined. Partitioning of iron between cytosolic and membrane-bound iron was generally consistent in each region, with a slightly higher proportion (55 \%) in the {\textquoteleft}insoluble{\textquoteright} phase. We expand on this using the Allen Human Brain Atlas to examine patterns between iron levels and transcriptomic expression of iron regulatory proteins and using quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry to assess regional differences in the molecular masses to which cytosolic iron predominantly binds. Approximately 60 \% was associated with ferritin, equating to approximately 25 \% of total tissue iron essentially in storage. This study is the first of its kind in human brain tissue, providing a valuable resource and new insight for iron biologists and neuroscientists, alike.",
keywords = "Aging, Ferroprotein, Inductively coupled plasma-mass spectrometry, Iron",
author = "McAllum, \{Erin J.\} and Hare, \{Dominic J.\} and Irene Volitakis and McLean, \{Catriona A.\} and Bush, \{Ashley I.\} and Finkelstein, \{David I.\} and Roberts, \{Blaine R.\}",
note = "Funding Information: Funding for this project was provided by the National Health \& Medical Research Council and Australian Research Council . EJM is supported by an NHMRC-ARC Dementia Research Development Fellowship ( GNT1105791 ); DJH is the recipient of an NHMRC Career Development Fellowship – Industry ( GNT1122981 ) in partnership with Agilent Technologies Australia. AIB is an NHMRC Senior Principal Research Fellow ( GNT 1103703 ), and DJH and AIB are supported by an ARC Discovery Project ( DP180101248 ). BRR receives an NHMRC Boosting Dementia Research Leadership Fellowship ( GNT1138673 ) and NHMRC project grant ( GNT1164692 ). This work was also supported by an ARC Linkage Grant ( LP14010095 ) to DJH and BRR, also supported by Agilent Technologies. The Florey Institute of Neuroscience and Mental Health acknowledge the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. Funding Information: Funding for this project was provided by the National Health \& Medical Research Council and Australian Research Council. EJM is supported by an NHMRC-ARC Dementia Research Development Fellowship (GNT1105791); DJH is the recipient of an NHMRC Career Development Fellowship ? Industry (GNT1122981) in partnership with Agilent Technologies Australia. AIB is an NHMRC Senior Principal Research Fellow (GNT 1103703), and DJH and AIB are supported by an ARC Discovery Project (DP180101248). BRR receives an NHMRC Boosting Dementia Research Leadership Fellowship (GNT1138673) and NHMRC project grant (GNT1164692). This work was also supported by an ARC Linkage Grant (LP14010095) to DJH and BRR, also supported by Agilent Technologies. The Florey Institute of Neuroscience and Mental Health acknowledge the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. Publisher Copyright: {\textcopyright} 2019 Elsevier Ltd",
year = "2020",
month = mar,
doi = "10.1016/j.pneurobio.2019.101744",
language = "English",
volume = "186",
journal = "Progress in Neurobiology",
issn = "0301-0082",
publisher = "Elsevier",
}